These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1982761)

  • 61. Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels.
    Rodrigo G; Rodrigo C
    Am J Emerg Med; 1996 Mar; 14(2):144-50. PubMed ID: 8924135
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Protective action of broxaterol in bronchial spasm induced by ultrasonic mist].
    Aversa C; Scorrano F; Scoditti S; Pancosta G; Stomeo S
    Arch Monaldi Mal Torace; 1988; 43(3):243-8. PubMed ID: 2908378
    [No Abstract]   [Full Text] [Related]  

  • 64. Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler.
    Mellén A; Arvidsson P; Palmqvist M; Lötvall J
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1663-5. PubMed ID: 10228142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma.
    Dockhorn R; Vanden Burgt JA; Ekholm BP; Donnell D; Cullen MT
    J Allergy Clin Immunol; 1995 Jul; 96(1):50-6. PubMed ID: 7622763
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D; Vitale A; Lahiri B; ZuWallack R
    Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Comparative therapeutic effect of bronchodilator aerosols and salbutamol cyclocaps].
    Ninković M; Bjelajac D; Ranković B; Dangubić V; Plavec G
    Vojnosanit Pregl; 1993; 50(6):589-92. PubMed ID: 8197732
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
    Lebecque P; Vliers S; De Saint-Moulin T; Godding V
    Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation.
    Jaeschke R; Guyatt GH; Cook D; Morris J; Willan A; McIlroy W; Harper S; Ramsdale H; Haddon R; Fitzgerald MJ
    Respir Med; 1993 Aug; 87(6):433-8. PubMed ID: 8105519
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD.
    Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S
    Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute cardiovascular effects of salmeterol in subjects with stable bronchial asthma.
    Bagnato GF; Mileto A; Gulli S; Oriti S; Di Cesare E; Cinquegrani M; Bonaiuto M; Saitta A; Purello D'Ambrosio F
    Monaldi Arch Chest Dis; 1996 Aug; 51(4):275-8. PubMed ID: 8909010
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cilomilast (Ariflo) does not potentiate the cardiovascular effects of inhaled salbutamol.
    Murdoch RD; Cowley H; Kelly J; Higgins R; Webber D
    Pulm Pharmacol Ther; 2002; 15(6):521-7. PubMed ID: 12493339
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma.
    Douglas JG; Leslie MJ; Crompton GK; Grant IW
    Br J Dis Chest; 1986 Jan; 80(1):55-8. PubMed ID: 3947525
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of innovator and generic salbutamol inhalers: a double-blind randomized study of efficacy and tolerance.
    Pinto Pereira LM; Clement YN; Pinto Pereira SM
    Int J Clin Pharmacol Res; 2002; 22(3-4):73-80. PubMed ID: 12837043
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.
    Cockcroft DW; Davis BE; Swystun VA; Marciniuk DD
    J Allergy Clin Immunol; 1999 Jun; 103(6):1049-53. PubMed ID: 10359885
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease.
    Georgopoulos D; Wong D; Anthonisen NR
    Chest; 1990 Feb; 97(2):280-4. PubMed ID: 1967572
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
    Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
    Löfdahl CG; Bengtsson B; Svedmyr K; Svedmyr N
    Allergy; 1982 Jul; 37(5):351-7. PubMed ID: 6127039
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.
    Geraghty R; Foster C; Black D; Roe S
    Respir Med; 1993 Jul; 87(5):375-8. PubMed ID: 8209057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.